Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer
- Status
- WITHDRAWN
- Phase
- NA
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
- Status
- COMPLETED
- Phase
- N/A
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Value of Various Chemokines in the Detection and Follow up of RCC
- Status
- UNKNOWN
- Phase
- N/A
Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- NA
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AMG 172 First in Human Study in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1